BioProcess International Asia is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Yang is a seasoned executive in biopharmaceutical industry. He is now Senior VP for Product & Process Development and General Manager of CDMO Business Unit at Hangzhou Just Biotherapeutics Ltd (Just China). Just China is the commercial development and manufacturing partner of Just Biotherapeutics (JUST) that is invested by Bill & Melinda Gates Foundation, Merck Co., Lilly Asia Ventures and ARCH Venture Partners, founded by the senior veterans of Amgen, a world leading biopharmaceutical company.
JUST leverages the most innovative and proprietary platform, and combines intensified process development of antibody with highly integrated production flow, modularized factory design, as well as disposable technology to ensure flexible and efficient biologics manufacture. We specialize in developing anti-tumor and anti-infectious biosimilars, bio-betters and innovative drugs that are in line with international standards.
Dr. Yang’s distinguished career includes increasing roles in major US biopharmaceutical companies and institution, include Merck & Co. as GMP manufacturing area-head, Johns Hopkins Medical School as Gene Therapy Facility Operation Director, Allergan, as bioprocess department head, and at Amgen as Scientific Director. During his tenture, he has created key technology platforms, led and participated in commercial product development including Rapatha®(Evolocumab), Amjevita® , Prolia®/Xgeva®(Denosumab) and Nplate® (romiplostim).
Dr. Yang is well recognized world-wide as Fellow of Society for Industrial Microbiology and Biotechnology (SIMB), Senior Editor for Journal of Industrial Microbiology & Biotechnology, Advisory Board member for BioProcess International journal.